MediPharm Labs Corp.
LABS.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.26M | -5.42M | -7.83M | -8.65M | -9.84M |
| Total Depreciation and Amortization | 1.38M | 1.61M | 1.90M | 2.03M | 2.11M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 474.40K | 850.30K | 1.18M | 2.01M | 879.60K |
| Change in Net Operating Assets | -940.20K | -1.56M | 1.20M | 2.91M | 3.22M |
| Cash from Operations | -5.35M | -4.52M | -3.55M | -1.71M | -3.63M |
| Capital Expenditure | -115.30K | -125.80K | -112.10K | -168.20K | -337.80K |
| Sale of Property, Plant, and Equipment | 3.07M | 15.30K | 420.30K | 551.10K | 1.97M |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | 3.12M | 3.12M |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 2.95M | -110.50K | 308.20K | 3.51M | 4.76M |
| Total Debt Issued | 550.00K | 799.00K | 799.00K | 799.00K | 749.00K |
| Total Debt Repaid | -2.98M | -3.05M | -3.05M | -3.11M | -1.20M |
| Issuance of Common Stock | 14.00K | 14.00K | 14.00K | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 186.00K | 244.00K | 391.00K | 462.00K | 531.00K |
| Cash from Financing | -1.63M | -1.45M | -1.35M | -1.35M | 51.60K |
| Foreign Exchange rate Adjustments | 18.20K | 6.00K | 3.80K | -337.50K | -279.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.00M | -6.07M | -4.59M | 106.60K | 896.10K |